42
Participants
Start Date
September 13, 2024
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Sacituzumab govitecan
Dose of 10 mg/kg intravenously
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
NOT_YET_RECRUITING
Complexo Hospitalario Universitario de Ferrol, Ferrol
RECRUITING
Institut Catala d´Oncologia (ICO) -Hospitalet, Hospitalet de Llobregat (Barcelona)
RECRUITING
Hospital Clínico San Carlos, Madrid
RECRUITING
Hospital Universitario la Paz, Madrid
NOT_YET_RECRUITING
Hospital Universitario Ramón y Cajal, Madrid
RECRUITING
MD Anderson Cancer Center Madrid, Madrid
RECRUITING
Hospital General Universitario Morales Meseguer, Murcia
RECRUITING
Hospital Universitario Central de Asturias, Oviedo
RECRUITING
H.U. Marqués de Valdecilla, Santander
RECRUITING
Hospital Universitario Miguel Servet, Zaragoza
Collaborators (1)
MFAR
OTHER
Gilead Sciences
INDUSTRY
Grupo Espanol de Tumores Neuroendocrinos
OTHER